12982 Federal Register / Vol. 80, No. 48 / Thursday, March 12, 2015 / Notices 

4See the Department’s memorandum from 

Christian Marsh, Deputy Assistant Secretary for 

Antidumping and Countervailing Duty Operations, 

to Paul Piquado, Assistant Secretary for 

Enforcement and Compliance, entitled, ‘‘Issues and 

Decision Memorandum for the Final Results of the 

Expedited Second Sunset Review of the 

Antidumping Duty Order on Tetrahydrofurfuryl 

Alcohol From the People’s Republic of China,’’ 

dated concurrently with this notice. 

5On November 24, 2014, Enforcement and 

Compliance changed the name of Enforcement and 

Compliance’s AD and CVD Centralized Electronic 

Service System (‘‘IA ACCESS’’) to AD and CVD 

Centralized Electronic Service System (‘‘ACCESS’’). 

The Web site location was changed from http://

iaaccess.trade.gov to http://access.trade.gov. The 

Final Rule changing the references to the 

Regulations can be found at 79 FR 69046 

(November 20, 2014). 

alcohol, is a clear, water white to pale 

yellow liquid. THFA is a member of the 

heterocyclic compounds known as 

furans and is miscible with water and 

soluble in many common organic 

solvents. THFA is currently classifiable 

in the Harmonized Tariff Schedules of 

the United States (‘‘HTSUS’’) under 

subheading 2932.13.00.00. Although the 

HTSUS subheadings are provided for 

convenience and for customs purposes, 

the Department’s written description of 

the merchandise subject to the order is 

dispositive. 

Analysis of Comments Received 

A complete discussion of all issues 

raised in this sunset review is provided 

in the accompanying Issues and 

Decision Memorandum, which is hereby 

adopted by this notice.4 The issues 

discussed in the Issues and Decision 

Memorandum include the likelihood of 

continuation or recurrence of dumping 

and the magnitude of the margins of 

dumping likely to prevail if the order 

were revoked. The Issues and Decision 

Memorandum is a public document and 

is on file electronically via Enforcement 

and Compliance’s Antidumping and 

Countervailing Duty Centralized 

Electronic Service System (‘‘ACCESS’’).5

ACCESS is available to registered users 

at http://access.trade.gov and to all 

parties in the Central Records Unit, 

Room 7046 of the main Department of 

Commerce building. In addition, a 

complete version of the Issues and 

Decision Memorandum can be accessed 

at http://enforcement.trade.gov/frn/. 

The signed Issues and Decision 

Memorandum and the electronic 

version of the Issues and Decision 

Memorandum are identical in content. 

Final Results of the Sunset Review 

Pursuant to sections 751(c)(1) and 

752(c)(1) and (3) of the Act, the 

Department determines that revocation 

of the Order would be likely to lead to 

continuation or recurrence of dumping 

at weighted-average dumping margins 

up to 136.86 percent. 

Notification Regarding Administrative 

Protective Orders 

This notice also serves as the only 

reminder to parties subject to 

administrative protective orders 

(‘‘APO’’) of their responsibility 

concerning the return or destruction of 

proprietary information disclosed under 

APO in accordance with 19 CFR 

351.305. Timely notification of the 

return or destruction of APO materials 

or conversion to judicial protective 

order is hereby requested. Failure to 

comply with the regulations and terms 

of an APO is a violation which is subject 

to sanction. 

We are issuing and publishing the 

results and notice in accordance with 

sections 751(c), 752(c), and 777(i)(1) of 

the Act and 19 CFR 351.218. 

Dated: March 3, 2015. 

Paul Piquado, 

Assistant Secretary for Enforcement and 

Compliance. 

[FR Doc. 2015–05713 Filed 3–11–15; 8:45 am] 

BILLING CODE 3510–DS–P 

DEPARTMENT OF COMMERCE 

United States Patent and Trademark 

Office 

[Docket No. PTO–P–2015–0009] 

Grant of Interim Extension of the Term 

of U.S. Patent No. 5,610,059; 

Monovalent Lawsonia Intracellularis 

Bacterin Vaccine 

AGENCY: United States Patent and 

Trademark Office, Commerce. 

ACTION: Notice of Interim Patent Term 

Extension. 

SUMMARY: The United States Patent and 

Trademark Office has issued an order 

granting interim extension under 35 

U.S.C. 156(d)(5) for a one-year interim 

extension of the term of U.S. Patent No. 

5,610,059. 

FOR FURTHER INFORMATION CONTACT: 

Mary C. Till by telephone at (571) 272– 

7755; by mail marked to her attention 

and addressed to the Commissioner for 

Patents, Mail Stop Hatch-Waxman PTE, 

P.O. Box 1450, Alexandria, VA 22313– 

1450; by fax marked to her attention at 

(571) 273–7755; or by email to 

Mary.Till@uspto.gov. 

SUPPLEMENTARY INFORMATION: Section 

156 of Title 35, United States Code, 

generally provides that the term of a 

patent may be extended for a period of 

up to five years if the patent claims a 

product, or a method of making or using 

a product, that has been subject to 

certain defined regulatory review, and 

that the patent may be extended for 

interim periods of up to one year if the 

regulatory review is anticipated to 

extend beyond the expiration date of the 

patent. 

On January 15, 2015, the Arizona 

Board of Regents, on behalf of the 

University of Arizona, the patent owner 

of record, timely filed a second 

application under 35 U.S.C. 156(d)(5) 

for an interim extension of the term of 

U.S. Patent No. 5,610,059. The patent 

claims the veterinary biological product 

monovalent Lawsonia intracellularis 

bacterin vaccine. The original 

application indicates that Intervet, a 

licensee of the patent owner, submitted 

two Product License Applications (PLA) 

to the United States Department of 

Agriculture (USDA). In a letter dated 

April 12, 2011, USDA acknowledged 

receipt of the PLA for a multi-valent 

vaccine and assigned the vaccine 

product code 49L5.RO. In a letter dated 

December 22, 2011, USDA 

acknowledged receipt of a PLA for a 

monovalent vaccine of Lawsonia 

intracellularis bacterin and assigned the 

vaccine product code 2799.20. 

Review of the application indicates 

that, except for permission to market or 

use the product commercially, the 

subject patent would be eligible for an 

extension of the patent term under 35 

U.S.C. 156, and that the patent should 

be extended for one year as required by 

35 U.S.C. 156(d)(5)(B). Because the 

regulatory review period will continue 

beyond the extended expiration date of 

the patent, March 11, 2015, interim 

extension of the patent term under 35 

U.S.C. 156(d)(5) is appropriate. 

An interim extension under 35 U.S.C. 

156(d)(5) of the term of U.S. Patent No. 

5,610,059 is granted for a period of one 

year from the extended expiration date 

of the patent. 

Dated: March 2, 2015. 

Andrew Hirshfeld, 

Deputy Commissioner for Patent Examination 

Policy, United States Patent and Trademark 

Office. 

[FR Doc. 2015–05581 Filed 3–11–15; 8:45 am] 

BILLING CODE 3510–16–P 


asabaliauskas on DSK5VPTVN1PROD with NOTICES